Adrenaline nasal spray for anaphylaxis

Video 19 of 38
2 min 32 sec
English
English
Want to watch this video? Sign up for the course or enter your email below to watch one free video.

Unlock This Video Now for FREE

This video is normally available to paying customers.
You may unlock this video for FREE. Enter your email address for instant access AND to receive ongoing updates and special discounts related to this topic.

MHRA Approves the First Needle-Free Adrenaline Nasal Spray for Anaphylaxis

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a major new development in the treatment of severe allergic reactions. For the first time in the UK, a needle-free adrenaline nasal spray has been authorised for emergency use in cases of anaphylaxis — a sudden, severe, and potentially life-threatening allergic reaction.

A New Alternative to Traditional Adrenaline Auto-Injectors

Until now, adrenaline for anaphylaxis has always been delivered by injection, typically using auto-injectors such as the EpiPen. These devices are highly effective, but for some people — particularly those with a strong fear of needles or who struggle to administer an injection during a crisis — they can present challenges.

The newly approved nasal spray provides a needle-free, single-dose, ready-to-use alternative. Administered through the nostril, the spray delivers adrenaline rapidly into the bloodstream via the nasal mucosa.

Who Can Use It?

The spray is approved for:

  • Adults
  • Children weighing 30 kg or more (typically around 10 years old and above)

Nasal Spray vs Adrenaline Auto-Injectors

The MHRA has emphasised that this new nasal spray does not replace traditional adrenaline auto-injectors. Adrenaline pens remain vital, effective, and life-saving tools. Anyone who currently carries an auto-injector must continue to do so.

Instead, the nasal spray adds an additional safe and effective option — particularly helpful for situations where injections are difficult, delayed, or distressing.

Key Points to Know

  • The spray can be used even if the casualty has a blocked or congested nose.
  • People at risk of anaphylaxis should always carry two doses, regardless of whether they use a spray or an auto-injector.
  • Family members, friends, colleagues, and teachers should know how to recognise anaphylaxis and administer treatment.

MHRA Approval and Safety

The decision follows a detailed review of clinical evidence showing that the nasal spray delivers adrenaline safely and effectively. This innovation marks an important advancement, making emergency treatment more accessible and user-friendly for people living with severe allergies.

What to Do in Suspected Anaphylaxis

Regardless of the type of adrenaline used, the priorities remain unchanged:

  • Recognise the symptoms quickly
  • Administer adrenaline without delay
  • Call 999 immediately
  • Continue to monitor and support the casualty until emergency help arrives

This new needle-free adrenaline spray represents a significant step forward in emergency allergy treatment — offering greater choice, improved accessibility, and a potentially easier way to deliver life-saving care when every second counts.